Exabis Library
Welcome to the e-CCO Library!
P107: IL-34 and IL-36 family expressing cytotoxic T-cells and plasmacytoid dendritic cells are increased
in patients with active inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P107: IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes in Crohn's disease patients
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P107: Lactobacillus plantarum 06CC2 induces intestinal IL-10–producing dendritic cells to ameliorate acute experimental colitis in mice
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P107: MicroRNA signatures can differentiate the inflamed colonic mucosa from non-inflamed mucosa in ulcerative colitis patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P107: Monitoring inflammatory bowel disease in clinical practice using gut microbial markers in faecal samples. Prospective study in a clinical cohort.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P107: Value of faecal biomarkers are affected by extension of inflammation in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P108 The importance of developing consensus-driven clinical data standards for Crohn’s disease to amplify data
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P108: Cytokine levels differ during pregnancy amongst women with ulcerative colitis and Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P108: Development and evaluation of the i-Tracker Risankizumab and i-Tracker Anti-Risankizumab kits: rapid and innovative tests intended for monitoring patients treated with Risankizumab.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P108: Differential expression in colitis-associated cancer compared with Crohn’s disease and ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P108: Identifying Patient-Centered Future Research Priorities: A Report from the Patient Reported Outcomes after Pouch Surgery (PROPS) Delphi Consensus Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P108: Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P108: Validation of a new score for paediatric Crohn's disease on a paediatric tertiary hospital: the MINI-Index (Mucosal Inflammation Non-Invasive Index)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P109 Construction of a suite of computable biological network models focused on inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P109: Analysis of the clinical, gastroscopic, and pathological features of upper gastrointestinal lesions in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P109: Effect of dysbiosis on the growth and colitis susceptibility in DSS colitis model
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P109: Impact of ethnicity on colorectal cancer incidence in a cohort of colitis-associated dysplasia patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P109: Profiling of receptor for advanced glycation end products expression in cases of primary sclerosing cholangitis with ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P109: Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM